Research graph
References from Temporal trends of outcomes following first hospitalization due to atrial fibrillation- a population-based study. Local targets link to admitted publications; unresolved targets remain external evidence.
Association between triglyceride-glucose index and atrial fibrillation: a retrospective observational study
10.3389/fendo.2022.1047927 · 2022 · External reference
Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights
10.1161/circresaha.120.316340 · 2020 · External reference
Worldwide Epidemiology of atrial fibrillation: a global burden of disease 2010 study
10.1161/circulationaha.113.005119 · 2014 · External reference
Early rhythm-control therapy in patients with atrial fibrillation
10.1056/nejmoa2019422 · 2020 · External reference
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry
10.1093/europace/euad280 · 2023 · External reference
Catheter ablation for atrial fibrillation and impact on clinical outcomes
10.1093/ehjopen/oeae058 · 2024 · External reference
Time trends in patient characteristics, anticoagulation treatment, and prognosis of incident Nonvalvular atrial fibrillation in the Netherlands
10.1001/jamanetworkopen.2023.9973 · 2023 · External reference
Nationwide epidemiology and management time trends for atrial fibrillation
2026 · External reference
Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study
10.1136/jnnp-2015-311947 · 2017 · External reference
Long-term outcomes after hospitalization for atrial fibrillation or flutter
10.1093/eurheartj/ehae204 · 2024 · External reference
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation
10.1136/heartjnl-2020-318648 · 2021 · External reference
Two aspects of labor mobility: a bivariate Poisson regression approach
10.1007/bf01176203 · 1993 · External reference
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
10.1161/jaha.116.005155 · 2017 · External reference
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007
10.1161/circoutcomes.111.962688 · 2012 · External reference
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries: 1993–2007
10.1161/circoutcomes.111.962688 · 2012 · External reference
Atrial fibrillation: a risk factor or risk marker?
10.1093/eurheartj/ehw313 · 2016 · External reference
30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death
10.1016/j.ijcard.2016.09.071 · 2016 · External reference
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
10.1161/jaha.116.005155 · 2017 · External reference
Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial
10.1001/jama.2019.0693 · 2019 · External reference
National trends in atrial fibrillation hospitalization, readmission, and mortality for medicare beneficiaries, 1999-2013
10.1161/circulationaha.116.022388 · 2017 · External reference
Apixaban versus warfarin in patients with atrial fibrillation
10.1056/nejmoa1107039 · 2011 · External reference
A comparison of outcomes with apixaban, rivaroxaban, and warfarin for atrial fibrillation and/or venous thromboembolism
10.1016/j.jacadv.2025.101714 · 2025 · External reference
2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024 · External reference
